Early-stage health technology, before the protocol is locked

We collaborate with early-stage health technology companies and startups based in New Zealand, Australia, or the UK, covering medical devices, digital health, diagnostics, and novel therapeutics, and targeting local and international markets, including New Zealand, Australia, the UK, and the US.

Our work is most valuable at the pre-protocol stage — before the clinical study is designed and before capital is committed to a development plan. The earlier we’re engaged, the better the evidence design and outcomes.